These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18565316)

  • 1. [Aromatase inhibitors for metastasing breast cancer in postmenopausal women. A survey of a Cochrane review].
    Aziz M; Skougaard K; Kamby C; Nielsen DL
    Ugeskr Laeger; 2008 Jun; 170(25):2248-52. PubMed ID: 18565316
    [No Abstract]   [Full Text] [Related]  

  • 2. Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer.
    Tuma RS
    J Natl Cancer Inst; 2006 Jan; 98(2):86-7. PubMed ID: 16418506
    [No Abstract]   [Full Text] [Related]  

  • 3. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G
    Oncol Nurs Forum; 2008 Jul; 35(4):714-21. PubMed ID: 18591176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [For postmenopausal women with hormone-dependent tumors. Aromatase inhibitors are the new gold standard].
    Jonat W
    MMW Fortschr Med; 2006 Mar; 148(12):10. PubMed ID: 16625996
    [No Abstract]   [Full Text] [Related]  

  • 5. Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
    Sánchez-Muñoz A; Ribelles N; Márquez A; Pérez-Ruiz E; Alba E
    J Clin Oncol; 2009 Dec; 27(35):e255-6; author reply e257-8. PubMed ID: 19884520
    [No Abstract]   [Full Text] [Related]  

  • 6. Aromatase inhibitors for early breast cancer therapy: a choice of effective treatment strategies.
    Dixon JM; Bundred N
    Eur J Surg Oncol; 2006 Mar; 32(2):123-5. PubMed ID: 16380226
    [No Abstract]   [Full Text] [Related]  

  • 7. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
    Dixon JM
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):453-63. PubMed ID: 18366292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer.
    Ryan PD; Goss PE
    Nat Clin Pract Oncol; 2005 Dec; 2(12):596-7. PubMed ID: 16341095
    [No Abstract]   [Full Text] [Related]  

  • 9. Current controversies in extended adjuvant endocrine therapy for early breast cancer.
    Snoj N; Paridaens R; Cufer T
    Curr Opin Oncol; 2008 Nov; 20(6):627-33. PubMed ID: 18841043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of postmenopausal status, age of the breast cancer patients and the outcome of aromatase inhibitors treatment.
    Aksoy S; Dizdar O; Altundag K
    Breast; 2008 Oct; 17(5):433-5. PubMed ID: 18565752
    [No Abstract]   [Full Text] [Related]  

  • 11. The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
    Winer E
    Clin Adv Hematol Oncol; 2008 Aug; 6(8):573-4. PubMed ID: 18820598
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
    Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H
    Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal therapy with aromatase inhibitor in advanced breast cancer].
    Vrbanec D; Belev B; Pavlinić-Diminić V; Pezerović D; Dusper B; Plestina S; Unusić J
    Lijec Vjesn; 1998; 120(10-11):315-8. PubMed ID: 19658346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aromatase inhibitors in the treatment of breast cancer].
    Ahokosk O; Salminen E
    Duodecim; 1997; 113(5):401-5. PubMed ID: 11370082
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-hormone breast cancer treatment. Convincing trials do exist--we have to take up a stand now!].
    Holmberg SB
    Lakartidningen; 2005 Oct 10-16; 102(41):2920-1. PubMed ID: 16294508
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.
    Toi M; Yamashiro H; Tsuji W
    Breast Cancer; 2009; 16(3):207-18. PubMed ID: 19259765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum use of aromatase inhibitors in the adjuvant treatment of early breast cancer.
    Buzdar AU; Cuzick J
    J Clin Oncol; 2005 Nov; 23(33):8544-6; author reply 8546-7. PubMed ID: 16293888
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormonal therapy in breast cancer].
    Espinós J; Reyna C; de la Cruz S; Oiler C; Hernández A; Fernández Hidalgo O; Santisteban M; García Foncillas J
    Rev Med Univ Navarra; 2008; 52(1):40-8. PubMed ID: 18578196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing aromatase inhibitor integration into initial treatment strategies in postmenopausal women with hormone-receptor-positive early breast cancer.
    Chlebowski RT
    Breast Cancer Res Treat; 2008 Dec; 112 Suppl 1():25-34. PubMed ID: 19101792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.